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Little is known about the role of islet delta cells in regulating blood glucose homeostasis
in vivo. Delta cells are important paracrine regulators of beta cell and alpha cell secretory
activity, however the structural basis underlying this regulation has yet to be determined.
Most delta cells are elongated and have a well-deﬁned cell soma and a ﬁlopodia-like
structure. Using in vivo optogenetics and high-speed Ca2+ imaging, we show that these
ﬁlopodia are dynamic structures that contain a secretory machinery, enabling the delta cell to
reach a large number of beta cells within the islet. This provides for efﬁcient regulation of
beta cell activity and is modulated by endogenous IGF-1/VEGF-A signaling. In pre-diabetes,
delta cells undergo morphological changes that may be a compensation to maintain paracrine
regulation of the beta cell. Our data provides an integrated picture of how delta cells can
modulate beta cell activity under physiological conditions.
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The islets of Langerhans have a unique cyto-architecturethat allows intimate and ﬁne-tuned functional inter-relationships between all structural components1–3. Auto-
crine and paracrine pathways are mediated by islet cells secreting
local-acting signalling molecules, such as acetylcholine4, gluta-
mate5,6, ATP7, and GABA8, in addition to the three peptide
hormones insulin, glucagon, and somatostatin. This arrangement
forms the basis for an adequate regulation of blood glucose
homeostasis under normal conditions, with disturbances in this
regulation underlying diabetes pathogenesis9. Somatostatin is a
powerful paracrine inhibitor of islet alpha and beta cells, which
express different isoforms of the somatostatin receptor10,11. These
receptors enable somatostatin-dependent suppression of glucagon
and insulin release12, indirectly impacting glucose home-
ostasis13,14. Delta cells release somatostatin in response to acet-
ylcholine15, glutamate6, urocortin3 (Ucn3)16, ghrelin11, and high
glucose17. Glucose-stimulated somatostatin release depends on
action potential ﬁring and subsequent Ca2+ inﬂux via L-, T-, R-,
and P/Q-type Ca2+ channels17. In addition, beta and delta cells
can regulate glucagon secretion by alpha cells through gap
junction communication18. However, the molecular machinery
underlying delta cell suppression of beta cell or alpha cell activity
under in vivo conditions is not clear. We now monitor delta cell
structure-function in vivo and in situ using light and electron
microscopy, Ca2+ imaging and optogenetics in healthy and pre-
diabetic mice. Delta cells within the islet respond to rising blood
glucose levels with a synchronized and fast increase in spiking
Ca2+ dynamics ([Ca2+]i), and this behavior is markedly impaired
in prediabetes. Moreover, delta cells have an IGF1/VEGF-A
responsive ﬁlopodia-like structure that is motile, with spiking
[Ca2+]i behavior and that enables delta cells to contact distant
alpha cells and beta cells. Furthermore, in mice with prediabetes,
delta cells have impaired [Ca2+]i dynamics and altered mor-
phology, which may contribute to early stages of beta cell failure
and diabetes pathophysiology.
Results
Delta cell activity is stimulated by glucose in vivo. In both
rodent and human islets, the somatostatin-secreting delta cells
make up 1–5% of the total islet cell population (Fig. 1a). In
rodents, delta cells are positioned in the outer islet mantle closer to
alpha cells, while in humans they are distributed throughout the
islet (Fig. 1a)1. Here, we monitored changes in delta cell cyto-
plasmic free Ca2+ concentration ([Ca2+]i) in vivo, as a surrogate
of delta cell secretory activity and somatostatin release, using a
mouse genetic model expressing the Ca2+-binding reporter pro-
tein GCaMP319 under the control of the SST promoter. Isolated
islets isolated from SST-GCaMP3 mice were transplanted into the
anterior chamber of the eye (ACE) of C57/BL6 mice20 and imaged
1 month later with in vivo two-photon microscopy (TPM).
Importantly, ACE islets re-vascularize and are re-innervated,
making them bona-ﬁde reporters of in situ islet function20–22. In
fasted animals, delta cells were active with fast [Ca2+]i spiking
activity under resting conditions (resting glucose levels 7–9mM,
Supplementary Movie 1). Next, to investigate the maximum
response of delta cells to an increase in circulating glucose levels,
we injected insulin (0.25 U/kg, 5–6min prior to imaging) to
induce a mild and transitory state of hypoglycemia (~5.5mM)
before in vivo imaging and glucose stimulation. This did not affect
overall glucose homeostasis (Supplementary Fig. 1A). Under basal
conditions (i.e., 5.5 mM glucose), ~94% of the cells had detectable
[Ca2+]i spiking activity that increased in response to glucose sti-
mulation (Fig. 1b, Supplementary Fig. 1B–D and Supplementary
Movie 2). In these cells, an increase in circulating glucose con-
centration (from ~5.5 to 18mM) promoted an increase in [Ca2+]i
spike frequency and amplitude that persisted for up to 4 min after
treatment (Fig. 1b–e). At 12 min after stimulation, [Ca2+]i spikes
were markedly reduced in frequency and amplitude as cells
entered into a recovery phase (Fig. 1b–d). The remaining ~6% of
delta cells exhibited slower, glucose-responsive [Ca2+]i dynamics
(Fig. 1b, Supplementary Fig. 1D). Cells with slow [Ca2+]i
dynamics displayed a signiﬁcant reduction in [Ca2+]i frequency
and amplitude ~3 min post stimulation, akin to spiking delta cells
(Fig. 1b–e). Together, these results indicate that there are two
functionally distinct types of delta cells that can be distinguished
by their [Ca2+]i responses to glucose stimulation.
Our results suggest that under basal conditions the activity of
individual delta cells within the islet is “uncoordinated” (e.g., each
delta cell can ﬁre at different time points) and that glucose
stimulation synchronizes delta cell [Ca2+]i spiking activity (Fig. 1b
and Supplementary Movie 1–2). We tested this hypothesis by
determining the degree of correlation between delta cells followed
by hierarchical cluster analysis (HCA) during basal (t= 0–2 min),
glucose-stimulated (t= 2–6 min), and recovery states (t > 6min).
This approach considers the activity proﬁle of each delta cell
during the speciﬁed time points and determines the degree of
correlation (or similarity), which is then ordered by hierarchical
clustering. We observed that glucose increases the number of
delta cells with similar activity patterns up to 4 min after
stimulation, thus creating highly synchronized delta cell clusters
within the islet (Fig. 1f). Delta cell synchronization increased
[Ca2+]i spike amplitude in response to glucose (Fig. 1g). While
the factors that synchronize delta cells remain to be determined, it
is possible that factors secreted from neighboring cells, the
autonomic nervous system and/or gap junction communication
may contribute to delta cell synchronization11,15,18. Our ﬁndings
support the idea that somatostatin and insulin are present in the
islet interstitium at the same time, as suggested by previous
in vitro studies23. However, different delta cell [Ca2+]i dynamics
have been observed in isolated islets in vitro11,24, which
underscores the likely contributions of other regulatory pathways
that are present in the in vivo setting, such as the vasculature and
the autonomic nervous system25.
Delta cells reach out towards other endocrine cells. Delta cells
are elongated, typically having a well-deﬁned cell soma and a
ﬁlopodia-like extension26,27. We hypothesized that the ﬁlopodia-
like structures compensate for the low density of delta cells
(Fig. 1), by enhancing the range of somatostatin action within the
islet and used confocal and electron microscopy to visualize these
structures in rodent and human delta cells (Fig. 2a–c, Supple-
mentary Fig. 2A). First, we measured ﬁlopodia length in rodent
and human pancreas sections (Fig. 2d). The length varied from 1
to 18 µm, which is in agreement with previous reports26. Next, we
studied the dynamics of delta cell ﬁlopodia in vivo using TPM
imaging of SST-ChR2-YFP mouse islets transplanted to the ACE.
This animal model was chosen because (i) ChR2 channels are
tagged with a ﬂuorescent protein (YFP) and thus enable efﬁcient
visualization of the cell membrane in vivo and in vitro and (ii) it
allows optogenetic stimulation of delta cells (see below). In
addition, we used TPM imaging instead of conventional confocal
microscopy to prevent signiﬁcant ChR2 activation28. Delta cell
ﬁlopodia were signiﬁcantly longer in vivo than in ﬁxed sections,
ranging from 2 to 27 μm (Fig. 2d, and a 3D rendering of an in situ
Sst-ChR2 delta cell is shown in Supplementary Movie 3). This
difference is likely caused by shrinkage associated with paraf-
ormaldehyde ﬁxation. In both mouse and primate islets in situ,
somatostatin-positive ﬁlopodia could be observed in close contact
with alpha, beta, and other delta cells that were several microns
away (Supplementary Fig. 2B–D).
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These results suggest that delta cells could contact islet cells
beyond their immediate vicinity. To test this hypothesis, we used
automated cell segmentation algorithms29 to identify delta cells
and determine the physical advantage provided by ﬁlopodia
within the crowded islet environment (Supplementary
Fig. 3A–G). Using measurements collected in vivo (2–27 µm,
Fig. 2d), we observed that increasing the length of delta cell
ﬁlopodia signiﬁcantly increased the number of contacts with beta
and alpha cells within an islet (Fig. 2e, f, Supplementary
Fig. 3A–J). While this effect was modest in rodents, in human
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islets delta cell ﬁlopodia allowed an ~ tenfold increase in potential
direct interactions with beta and alpha cells (alpha, from 0.69 ±
1.49% to 6.3 ± 10.67%; beta, 0.48 ± 0.99% to 6.26 ± 10%, Fig. 2e).
These data conﬁrm that the ﬁlopodia are a potential avenue of
communication between delta cells and other neighboring
endocrine cells.
Delta cell ﬁlopodia are dynamic. The observed variations in
ﬁlopodial length (Fig. 2d) suggested that delta cell morphology
could be dynamic. We therefore used TPM to image, over spans
of hours (Fig. 2f) and days (Fig. 2g), single delta cells in vivo in
SST-ChR2-YFP islets transplanted into the ACE. To determine
the relative position of individual delta cells, we labeled the islet
vasculature with intravenously injected dye (150 kDa TRITC-
dextran) and then used the labeled islet capillaries as ﬁducial
markers30. We observed that delta cells were either positioned
directly along capillaries or were connected to the vascular net-
work via ﬁlopodia (Fig. 2f, g). Filopodia-dependent connections
between delta cells and islet vasculature occurred in situ (Sup-
plementary Fig. 4A, Supplementary Movie 4) and were stable for
days in vivo (Fig. 2g). However, ﬁlopodia not connected to the
vasculature were highly dynamic, exhibiting noticeable ﬁlopodia
extension, and repositioning over timescales as fast as 30 min
(Fig. 2f, Supplementary Fig. 4). These observations show that
delta cells can rapidly reposition their ﬁlopodia within the intra-
islet milieu, suggesting that the somatostatin signaling landscape
within the islet is dynamic.
We next considered the chemical signals that could drive
ﬁlopodia dynamics and thereby guide them towards their target
cells within the islet by considering three factors, namely insulin,
IGF-131 or VEGF-A32. Insulin was chosen because it is secreted
in abundance by beta cells, while VEGF-A was chosen due to the
fact that it is a beta cell-secreted factor that acts on endothelial
cells, which are in turn targeted by the delta cell ﬁlopodia (Fig. 2g,
Supplementary Fig. 4). Importantly, delta cells express insulin and
IGF-1 receptors (IGF-1R)11. Although incubating isolated mouse
islets for 24 h with high insulin (1 μM) may lead to a decrease in
ﬁlopodia length (p= 0.0284, FDR > 0.05), treatment with IGF-1
or VEGF-A did not noticeably affect ﬁlopodia length (Fig. 2h).
However, blockade of endogenous islet IGF-1 receptors11 with
picropodophyllin (PPP) or of VEGF-A receptors11 with axitinib
(Axtb) signiﬁcantly decreased ﬁlopodia length (Fig. 2h). While
these effects could not be reversed by IGF1 or VEGF-A treatment,
incubation with 1 μM insulin did restore normal ﬁlopodia length
in PPP-treated islets (Fig. 2h, see Supplementary Data 1–2 for
detailed statistics). These data suggest that endogenous VEGF,
IGF1, and insulin receptor signaling, in states of acute
hyperinsulinemia, can stimulate elongation of delta cell ﬁlopodia.
Secretory capacity and [Ca2+]i dynamics of delta cell ﬁlopodia.
We next asked whether delta cell ﬁlopodia have a secretory/reg-
ulatory role. From our in vivo TPM imaging dataset (Fig. 1), we
identiﬁed a total of ﬁve delta cells with discernable ﬁlopodia in
four different SST-GCaMP3 islets (n= 1 islet/mouse, total of four
different mice). Under resting conditions, delta cell somata and
ﬁlopodia displayed low amplitude [Ca2+]i spikes that were not
synchronized, with the ﬁlopodia displaying generally lower
amplitudes (Fig. 3a). Analyses of the ﬁrst 80 s after glucose
injection revealed a marked increase in [Ca2+]i spiking frequency
and spike amplitude in both cell compartments (Fig. 3a–f). In
some cases, ﬁlopodia exhibited [Ca2+]i spikes that were not
synchronized with somatic [Ca2+]i spikes (Fig. 3b, c). Because
glucose stimulation of somatostatin release depends on an
increase in [Ca2+]i17, these results indicate that somatostatin
secretion may occur independently from both the soma and
ﬁlopodia of delta cells. Another requirement for somatostatin
release from ﬁlopodia is [Ca2+]i-dependent membrane trafﬁcking
and vesicular exocytosis followed by membrane recycling via
endocytosis. We incubated isolated SST-ChR2-YFP islets with the
reporter dye FM-4-64 (Fig. 3g–i), a highly ﬂuorescent membrane
probe that labels internalized secretory vesicles31. We observed
FM-4-64 accumulation in the delta cell ﬁlopodia within minutes
(Fig. 3g–i), indicating active recycling of exocytotic vesicles.
Furthermore, several components required for SST secretion,
including the L-type Ca2+ channel subunit CaV1.2 (Supple-
mentary Fig. 5A–D), vesicle-associated membrane protein-2
(VAMP2) and synaptophysin (Supplementary Fig. 5E–T) were
observed in the ﬁlopodia in mouse and human delta cells.
We investigated the ultrastructure of delta cell ﬁlopodia at
nanometer resolution by performing multi-tilt electron tomo-
graphy on a 250-nm thick section of a mouse islet. We identiﬁed
two examples of delta cell ﬁlopodia (Fig. 3j and Supplementary
Fig. 6A) and performed 3D reconstruction of one delta cell
ﬁlopodium. The ﬁrst ﬁlopodium contained granules localized in
close proximity to both the plasma membrane and a microtubule
(Fig. 3j, k). The second ﬁlopodium had fewer granules and
contained mitochondria in the upper half, while the lower half
lacked granules and contained endoplasmic reticulum (Supple-
mentary Fig. 6A). We conﬁrmed the occasional existence of delta
cell ﬁlopodia lacking somatostatin in both mouse and human
islets with immunohistochemistry (Supplementary Fig. 6B–J).
These structures likely represent intermediates in the elongation
(or retraction) of delta cell ﬁlopodia. Together, our in vitro and
in vivo data support that the delta cell ﬁlopodia have dynamic
[Ca2+]i spiking behavior and somatostatin granules ﬁtted with
elements of an active exocytosis machinery, consistent with a
possible role for ﬁlopodia in somatostatin release (Fig. 3,
Supplementary Figs. 5 and 6).
Fig. 1 Delta cell activity in vivo. Delta cells are activated by increasing glucose levels. Longitudinal imaging of in vivo activity in islets expressing the Ca2+
reporter GCaMP3 in delta cells. a Maximum projection images a representative mouse (top) and a human islet (bottom) immunostained with anti-
glucagon, anti-insulin, and anti-somatostatin antibodies. Cell nuclei are shown in light blue. Graphs on the right show the cellular composition of mouse
(n= 24 islets total, n= 7 mice) and human islets (n= 21 islets total, n= 3 donors). b Individual traces from four representative delta cells within a single
islet in vivo and showing the proﬁle of spiking and slow delta cells. Insulin (0.25 U/kg) was injected 2min prior to glucose injection (0.4 g/kg i.v.). Gray-
shaded area indicates a predetermined time zone used for data analysis and marks the glucose stimulation period. Basal and recovery periods are located
to the left and right of the grey-shaded area, respectively. c Relative distribution (or frequency) of detected peaks in all spiking delta cells analyzed (n=
217) over the course of up to 18 min. Grey-shaded area represents the glucose-stimulated time period as described in b. d Normalized spiking delta cell
activity peak amplitude for basal (n= 4574 peaks); glucose (n= 7850 peaks); and recovery (n= 10518 peaks) time periods. In e, same as in d, however
the graph shows the breakdown of the normalized peak amplitude in the ﬁrst or last 2 min of the glucose stimulation time period. f Hierarchical clustering
analysis of the spiking delta cell activity under basal, the ﬁrst or last 2 min of glucose-stimulated or recovery time periods. g Normalized delta cell peak
amplitude in nonsynchronized (OFF) and synchronized (ON) peaks. In a, scale bar= 35 µm. Statistics: in c, *p= 0.0001 vs time 0 (d, e, and g) **p <
0.0001, (g) #p < 0.0001 vs respective OFF group. All comparisons made with OneWay Anova with a Tukey multiple comparison test. Error bars represent
the 95% conﬁdence interval (C.I.) of the mean. For a, c–e, and g, source data are provided as a Source Data ﬁle
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In vivo optogenetic activation of delta cells and beta cell
[Ca2+]i imaging. To determine whether somatostatin release
from delta cells exerts paracrine control over beta cells, we used
ChR2 to photostimulate delta cells in vivo. In SST-ChR2-YFP
islets, ChR2-YFP was expressed in ~80% of delta cells33 (Sup-
plementary Fig. 7A–D) and virtually all ChR2-YFP+ cells
expressed somatostatin (Supplementary Fig. 7E). SST-ChR2 mice
had normal glucose homeostasis (Supplementary Fig. 7F). In
pancreas slices, illumination of ChR2-expressing delta cells with a
470 nm light beam evoked an inward photocurrent (Fig. 4a; peak
amplitude 273+ 48 pA at −70 mV; n= 12). The exact impact of
photostimulation on membrane potential changes in the intact
cell, being spontaneously active, is not known. Nevertheless,
optogenetically evoked depolarizing currents were sufﬁcient to
obtain voltage changes mimicking the action potentials of the
delta cell (Fig. 4a) and similar to those evoked by depolarizing
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current pulses (Supplementary Fig. 7G). Hence, light could evoke
trains of action potential-like responses at frequencies up to 5 Hz,
as well as maximal somatostatin release34. Next, we combined
delta cell optogenetics with in vivo beta cell [Ca2+]i imaging by
transducing isolated control or Sst-ChR2 islets with vectors
encoding the Ca2+ reporter GCaMP635 under the control of the
insulin promoter. Sst-ChR2/Ins-GCaMP6 islets were transplanted
into the ACE of host mice and imaged under nonfasting condi-
tions with or without light stimulation (methods, Fig. 4b, c).
Without light stimulation, beta cells in both control and SST-
ChR2 islets displayed [Ca2+]i oscillations (Fig. 4d). Such oscilla-
tions were more frequent in ChR2 animals (Fig. 4b), likely due to
changes in basal delta cell activity by exposure to ambient light
prior to photostimulation. Upon light stimulation (four pulses,
each 15 s, details in the “Methods” section), beta cells of WT islets
responded heterogeneously, with either no change or a slight
increase in [Ca2+]i oscillation amplitude (Fig. 4e). This effect on
[Ca2+]i oscillations is likely due to light activating the pupillary
reﬂex and causing parasympathetic release of acetylcholine, which
enhances beta cell function4,36. In light-stimulated SST-ChR2
islets, most beta cells displayed reductions in [Ca2+]i oscillation,
amplitude, and frequency (Fig. 4e, f). On average, there was a
35% decrease when compared with nonstimulated conditions
(Fig. 4e, f), consistent with the reported transient inhibitory effect
of somatostatin on beta cell electrical activity37,38.
Delta cell activity is impaired in an animal model of pre-
diabetes. Earlier studies have suggested that delta cell activity
and/or somatostatin release is impaired in islets exposed in vitro
to free fatty acids39 and in animal models of prediabetes and
diabetes40,41. Prediabetes is a state where higher insulin demands
are compensated for by increased beta cell secretory activity,
followed by an adaptive proliferation of beta cells. To determine
the potential impact of prediabetes on delta cell function, mice
with SST-GCaMP3 islets engrafted for 1 month were fed a
chow (CD) or a high-fat diet (HFD) for 8 weeks. HFD-feeding
impaired glucose homeostasis and elevated fasting glucose levels
(Supplementary Fig. 8A, B). This phenotype was associated with a
trend towards increased beta cell number without any changes in
total islet area (Supplementary Fig. 9A, B), indicating that our
HFD feeding model recapitulates a prediabetes state that was
maintained for the duration of our in vivo imaging experiments
(Supplementary Fig. 8C). In control animals, glucose stimulation
signiﬁcantly increased delta cell [Ca2+]i spike amplitude (Fig. 5a,
b) but not spike frequency or cell synchronization 3 months after
ACE transplantation (Supplementary Fig. 8F–G). HFD-fed mice
exhibited a marked impairment of delta cell activity in response
to glucose stimulation, characterized by overall lower [Ca2+]i
peak amplitudes, a higher number of unresponsive cells, and a
doubling of the number of oscillatory cells that were also func-
tionally impaired (Supplementary Fig. 8D, E).
Next, we tested whether delta cells in HFD-fed animals
displayed signiﬁcant morphological changes when compared with
CD-fed islets and found that HFD feeding was associated with an
increase in delta cell ﬁlopodia length (Fig. 5c). As a result, the
total number of beta cells in direct contact with individual delta
cells, or with the entire delta cell population, was similar between
CD- and HFD-islets (Supplementary Fig. 9C, D). In addition, we
observed a similar contact density between delta and beta cells
when we simulated the contribution of the delta cell ﬁlopodia
(Supplementary Fig. 9E, F).
These results indicate that delta cell function is impaired
during the onset of hyperglycemia in prediabetic animals, a
physiological condition associated with beta cell expansion and
[Ca2+]i dysfunction21. Of note, the longer ﬁlopodia observed in
prediabetic delta cells may reﬂect adaptation to maintain contact
with beta cells in prediabetic mice (Fig. 5c, Supplementary
Fig. 8C–F).
Discussion
Delta cells are important paracrine regulators of alpha and beta cell
function13 and inhibit their activity (Fig. 4c–e) by secreting soma-
tostatin in response to paracrine or circulating stimuli11,15–17,42.
Consequently, delta cells can indirectly affect the control of glucose
homeostasis in health and disease43. However, it has been largely
unknown how delta cells are able to effectively regulate the function
of alpha and beta cells while being a relatively rare cell type among
the islet endocrine cell population (Fig. 1a 1,3). Furthermore, it has
been suggested that diabetes is associated with impaired somatos-
tatin release and/or delta cell death40,41,44.
We now show that the somatostatin-secreting delta cell is able
to rapidly inactivate beta cells in vivo, which serves as an efﬁcient
brake to prevent undesirable and deleterious overshooting of
insulin release. In vivo, delta cells are active under resting and
glucose-stimulated conditions and are rapidly inactivated after a
burst of glucose-induced activity. Besides glucose17,18, activation
of delta cells can also be mediated by insulin secreted from
neighboring beta cells in response to rising glucose levels45. Delta
cell ﬁlopodia are adapted to contact neighboring alpha and beta
cells, a phenomenon that is maximized in the human islet and
dependent on endogenous IGF1, insulin and VEGF signaling
pathways. Islet endocrine cells have been reported not to express
VEGFRs11. Hence, it is likely that the ﬁlopodia phenotype
observed after inhibition of VEGF signaling pathways is mediated
indirectly by islet endothelial cells, which remain in isolated islets
for days46. Filopodia are dynamic and somatostatin release com-
petent, allowing the delta cell to rapidly target different regions
within the islet. Furthermore, prediabetic conditions are sufﬁcient
to induce a state of hyperglycemia that is associated with
Fig. 2 Cyto-architecture of delta cells in rodents and human islets. Delta cells send out cellular processes (ﬁlopodia) to increase their intra-islet reach.
Maximum projection images of representative mouse (a) and a human delta cells (b) immunostained with anti-somatostatin antibodies. The yellow
arrowheads indicate cellular extensions from delta cells. c Scanning electron microscopy of a human islet. Somatostatin-expressing delta cell is highlighted
by a purple shade. Right, close-up image of the delta cell ﬁlopodia (highlighted by the cyan box in c) contacting an alpha and a beta cell. d Physical length of
the delta cell ﬁlopodia in its longest axis (tip to cell body) in vivo in mouse islets (empty black circles, n= 47 cells) and in PFA-ﬁxed pancreases from mice
(black circles, n= 31 cells) and human (pink circles, n= 57 cells) samples. e Relative reach of single delta cells towards alpha and beta cells in mouse (black
line) and human islets (purple line). f In vivo longitudinal follow up of a single delta cell at 10-min intervals or 19 h later. Delta cells were from SST-ChR2
islets and imaged with TPM to avoid rhodopsin activation28. A yellow line highlights the delta cell morphology over time. g In vivo longitudinal follow up of
a single delta cell ﬁlopodium over the course of 4 days as in f. Vessels were visualized by an i.v. injection of TRITC-labeled dextran molecules. Yellow
arrowheads indicate the ﬁlopodium from the same delta cell from days 1 to 4. h Delta cell ﬁlopodia length from isolated islets treated with insulin, IGF, and
VEGF-A with or without the IGF-1R receptor blocker picropodophyllin (PPP) or the VEGFR blocker Axitinib. Statistics shown for FDR (q < 0.005 for
discovery): *q= 0.052, p= 0.0284; **q < 0.002, p < 0.001, #q < 0.002, p < 0.001 vs control (DMSO) group. Detailed statistics shown in Supplementary
Data 1. Error bars represent the 95% conﬁdence interval (C.I.) of the mean. For d, e, and h, source data are provided as a Source Data ﬁle
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impairment of delta cell function and altered morphology. The
timescale of delta cell dysfunction parallels that of beta cells under
similar prediabetic conditions, where higher circulating insulin
and somatostatin levels should occur due to both increased basal
beta cell secretory activity21 and a direct stimulatory effect of
insulin on the delta cell45. Our results thus provide insight into the
activity of the delta cell in health and prediabetes and a possible
mechanism for somatostatin to effectively exert its potent sup-
pressive effects on islet beta and alpha cells and thereby act as an
efﬁcient modulator of glucose homeostasis.
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Methods
Animals. All animal procedures were approved by the Institutional Animal Care
and Use Committee (IACUC, protocol number 2013/SHS/816) of the SingHealth
system or the Karolinska Instituet (protocol number N34/16) and complied with all
relevant ethical regulations for animal testing and research. Transgenic mouse
strains used in this study were from Jackson Laboratories. For in vitro studies, male
and female mice were used. For in vivo imaging, female mice were used as donors
and recipients. The following strains were used: SST-CRE (Ssttm2.1(CRE)Zjh/J),
Ai32-ChR2-YFP (B6;129S-Gt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J), and
GCaMP3 (B6;129S-Gt(ROSA)26Sortm38(CAG-GCaMP3)Hze/J). Wild-type (WT) C57/
6NTac (In Vivos, Singapore) or C57/BL6J (Charles River, USA) mice were used as
hosts of Sst-ChR2 and Sst-GCaMP3 islets, respectively. Glucose tolerance tests
(GTT) were performed as described in30. Brieﬂy, animals were fasted for 4–6 h
after which the fasting blood glucose levels were measured at two time points 5 min
apart. Next, mice were injected with 2 g glucose/kg body weight and blood glucose
levels were measured every 15–30 min. For I.V.GTT in Sst-GCaMP3 transplanted
mice, animals were anesthetized according to the imaging protocol (i.e., i.p.
injection of a mixture of ﬂuanisone (25 mg/kg), fentanyl (0.788 mg/kg) and
Fig. 3 Islet delta cell ﬁlopodia have independent Ca2+ spikes from the soma and contain secretory granules. Delta cell ﬁlopodia display Ca2+ spikes in vivo
upon stimulation with glucose. a Representative Ca2+ dynamics of a delta cell soma (black line) and ﬁlopodia (pink) in vivo. Shaded grey area indicates
the time point when glucose (0.4 g/kg) was injected i.v. b Close-up of the area highlighted in grey in a, glucose stimulation time point is indicated by a
dashed line. Numbers on top of the peaks indicate the time point of the peak’s maximum amplitude. Values for the cell body are plotted on the left Y-axis
while values for the ﬁlopodia are plotted on the right Y-axis. Dotted line indicates the time point when glucose was injected. cMaximum projection images
of Ca2+ dynamics in delta cell body and ﬁlopodia, shown in a, b. Yellow squares mark the regions of interest represented in a, b. d Peak amplitude and
e frequency in delta cells (n= 5) with soma and ﬁlopodia regions at basal, glucose, and recovery time points. f Peak synchronization between the delta cell
soma and ﬁlopodia at basal, glucose, and recovery time points. g–i Single confocal slice of a delta cell ﬁlopodia from an SST-ChR2 islet incubated with FM-
4-64 at 3mM glucose. The delta cell ﬁlopodia plasma membrane was visualized by imaging YFP (g), FM-4-64 is shown in h and the overlay is shown in i.
Graph on the right of i indicates the pixel proﬁle of the region of interest (yellow line) drawn in i. YFP pixels (plasma membrane) are represented by a black
line and plotted on the right Y-axis. FM-4-64-pixel proﬁle is shown in pink and plotted on the left Y-axis. j Electronic tomogram of a delta cell ﬁlopodia in a
mouse islet, cytoplasm is highlighted by a purple shade. Orange arrowheads indicate a microtubule and yellow arrowheads point to somatostatin granules.
k 3D reconstruction of the volumetric data set shown in j. Filopodia plasma membrane is shown in white and somatostatin granules are shown in varying
colors. Scale bars, c 10 µm, g–i 5 µm, and in j, k 500 nm. Error bars represent the 95% conﬁdence interval (C.I.) of the mean. For d–f source data are
provided as a Source Data ﬁle
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Fig. 4 Optogenetic control of delta cell activity. Somatostatin reduces beta cell [Ca2+]i oscillatory frequency and peak amplitude, and hyperglycemia is
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voltage clamp conditions (top; holding potential=−70 mV) and light-evoked, overshooting action potential-like responses under current-clamp conditions
(bottom). Timing of light ﬂashes (470 nm) is indicated by lower traces (L). Dashed line= 0mV. b tdTomato and GCaMP6s/YFP ﬂuorescence signal in
wild-type and SST-ChR2 islets. c Top, protocol for in vivo imaging and ChR2-mediated photostimulation (450–470 nm light). Bottom, cartoon illustration
representing the experimental setup and expected biological responses of GCaMP6+ beta cells and ChR2+ delta cells. d Representative beta cell [Ca2+]i
traces in islets from wild-type (top) or SST-ChR2 mice (bottom). e Normalized beta cell [Ca2+]i peak amplitude and f peak frequency in wild-type (n= 7
islets) and SST-ChR2 islets (n= 5 islets) before and after ChR2 stimulation in vivo. e ***p < 0.001 by two-tailed student t-test and in f, ***p= 0.001 vs
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midazolam (12.5 mg/kg)), glucose was injected in the tail vein (0.4 g/kg) and blood
glucose was measured every 2 min (Accu-Check, Roche, Switzerland). For dietary
treatments, animals were assigned for 6–7 weeks to either a control diet, CD
(CD88137, 11% of energy from fat, 66% from carbohydrates, and 23% from pro-
teins) or to a HFD (TD88137, 43% of energy from fat, 42% from carbohydrates,
and 15% from proteins). Diets were acquired from Ssniff Spezialdiäten GmbH,
Soest, Germany.
Transplantation of islets into the anterior chamber of the eye (ACE) and
in vivo microscopy. Transplantation and in vivo imaging of ACE islets were
performed as previously described20. In brief, islets from SST-ChR2-YFP or SST-
GCaMP3 mice were isolated 24–48 h prior to transplantation using the collagenase
method and recovered in vitro with fresh CMRL-1066 or RPMI 1640 medium
supplemented with 10% fetal bovine serum. Delta cell GCaMP3 imaging was
performed under the following anesthesia conditions: mixture of ﬂuanisone
(25 mg/kg), fentanyl (0.788 mg/kg), and midazolam (12.5 mg/kg). To image delta
cell GCaMP3 in vivo (data shown in Fig. 1), animals were injected with insulin
(0.25U/kg) 2 min prior to the injection of glucose. We determined that this 2-min
time window would be used as a baseline for calculating the effect of glucose
stimulation on delta cell activity. Subsequent imaging of delta cell GCaMP3 in
animals fed CD or HFD diets did not involve insulin injection prior to glucose
stimulation. When beta cell function was investigated in WT or SST-ChR2-YFP
islets with GCaMP6s constructs, islets were transduced with an adenovirus carrying
a RIP2-GCaMP6s-IRES-tdTomato construct immediately after isolation and the
media was changed 24 h prior to transplantation. RIP2-GCaMP6s-IRES-tdTomato
adenoviruses were produced in HEK293 cells and harvested 4–6 days after initial
transfection. Next, 20 μL of the media containing the viruses was added to a 6-mm
dish containing the freshly-isolated islets in 2 mL of RPMI 1640 medium
supplemented with 10% fetal bovine for 16 h. The next day, the media was changed
and islets incubated for 6 h prior to transplantation. The efﬁciency of this trans-
duction protocol was variable (n= 2–50 beta cells GCaMP6s-positive 2 days after
transplantation) and the beta cells transduced were limited to the outer layers of
the islet. On average, 5–20 islets were transplanted into the right ACE of the host
mouse (8–12 weeks old) under anesthesia (2% isoﬂurane) as in reference20. In vivo
imaging was performed with an upright multiphoton SP5 or SP8 microscope. For
imaging delta cell function (SST-GCaMP3 mice), islets were allowed to engraft for
at least 30 days prior to imaging with single- and two-photon laser scanning
microscopy. For imaging beta cell function (WT or SST-ChR2-YFP islets trans-
duced with the RIP2-GCaMP6s-IRES-tdTomato construct), islets were engrafted
for 10–12 days prior to start of the experiments. In vivo optogenetic stimulation of
delta cells was performed by pulsing (4 × 15-s pulses) a blue light (450–490 nm)
through the imaging objective focused on the engrafted islet (Fig. 4a). For mon-
itoring of delta cell ﬁlopodia movement, SST-ChR2-YFP islets were imaged 90 days
after transplantation. To avoid uncontrolled activation of delta cell ChR2 during
imaging, islets and delta cells were imaged with two-photon LSM using a bidir-
ectional resonant scanner (8000 Hz, Ex 970 nm Em 500–550 nm), that does not
activate ChR228. Imaging of GCaMP6s and tdTomato in controls and SST-ChR2-
YFP islets was achieved with a laser wavelength of 1000 nm. Beta cells were
identiﬁed by green (GCaMP6s) and red (tdTomato) ﬂuorescence signal. ChR2-YFP
delta cells were identiﬁed by a weak green (YFP) ﬂuorescence. Eventual drifts
in X, Y, and Z were corrected post hoc with custom registration algorithms
described in ref. 47.
Islet immunohistochemistry. Immunohistochemistry of pancreas and isolated
islets was performed in 30–40 µm thick pancreas slices or isolated islet whole
mounts as described before30. In brief, mouse and human pancreata were ﬁxed
overnight in fresh 4% paraformaldehyde and cryo-protected in 30% sucrose for
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12 h and embedded in OCT and sectioned. Human pancreas was from cadaveric
donors (n= 5, Singapore General Hospital). Use of human tissues (with no
traceable information besides age and sex) was approved by the SingHealth Cen-
tralized Institutional Review Board (IRB#2013-504-A), complied with all relevant
ethical regulations for use of human tissues in research and had donor consent for
use in research and publication. The following primary antibodies were used:
guinea pig anti-insulin (pancreas 1:400, isolated islets 1:1500, Dako - A0564),
mouse anti-glucagon (1:400, Sigma-Aldrich—G2654), rat anti-somatostatin (pan-
creas, 1:400 Millipore—AB5494, isolated islets 1:700, BioRad 8330-0009), goat anti-
CD31 (1:100, RD Systems—AF3628), rabbit anti-VAMP2 (1:100, Cell Signaling—
13508 S), rabbit anti-synaptophysin (1:100, Abcam—ab32594), and rabbit anti-
CaV1.2 (1:50, Alomone—ACC-003). Secondary antibodies were raised in donkey
and were conjugated to Alexa 488, 546, 561, or 647 ﬂuorophores. Nuclei were
labeled with DAPI (1:400, Invitrogen). Incubation of isolated SST-ChR2 islets with
FM-4-64 (Invitrogen, T13320) was performed at room temperature (~23 oC),
according to manufacturer guidelines. Islets were incubated with FM-4-64 at low
glucose (3 mM) in Ca2+ buffered solution (125 mM NaCl, 5.9 mM KCl, 2.56 mM
CaCl2, 1.2 mM MgCl2, and 25 mM HEPES) for 3 min the day after isolation
and overnight recovery in vitro. After incubation, islets were ﬁxed in 4% PFA
for 30 min, mounted on a coverslip and prepared for imaging.
Simulation of delta cell contact densities and reach in islet sections. Mouse
and human islets immunostained with anti-insulin, -glucagon, and/or -soma-
tostatin antibodies and DAPI were mapped using an imageJ plugin as previously
described29. In brief, the nuclei and cells are segmented in 3D, which generates a
“geographical” map of alpha, beta, and/or delta cells in XY and Z planes of each
islet (Supplementary Fig. 3A–C). Next, we determined the number of direct delta
cell contacts (characterized by adjacent cell boundaries29) with neighboring alpha
or beta cells. This information is translated into a measure of “contact frequency”,
which is the percentage of alpha or beta cells contacted by a given delta cell (e.g., if
a delta cell contacts 2 out of 20 total mapped alpha cells, that delta cell’s contact
frequency with alpha cells is 10%). This process is repeated for each delta cell
mapped. Next, once the position of each alpha and/or beta and delta cell is
known, we simulate the expected contact density that would be observed if the
boundaries of each delta cell were expanded by 1 µm increments in all possible
directions (except towards the outside of the islet structure) until it reaches a
maximum “ﬁlopodia length” value determined by the user (Supplementary
Fig. 3J).
In vitro islet treatment with axitinib, picropodophyllin, or insulin. Isolated islets
were used 6 h after isolation and incubated with the VEGFR inhibitor (axitinib,
Sigma-Aldrich, 0.1 µM) and/or the IGF-1R inhibitor (Picropodophyllin, PPP,
Sigma-Aldrich, 0.1 µM) for 30–60 min prior to incubation with VEGF-A (Pepro-
Tech #450-32, 100 ng/mL), IGF-1 (Novus Biologicals 791-MG, 20 ng/mL) or
insulin (NovoNordisk, 1 µM) for the following 24 h. After incubation, isolated islets
were ﬁxed in 4% PFA for 30 min and immunohistochemistry was performed as
described above. Measurements of delta cell ﬁlopodia for all experimental groups
were performed in a blind fashion, where the person analyzing the images did not
know the identity of all experimental groups until the analysis was completed.
High-resolution confocal imaging of pancreatic islets and imaging processing.
Confocal imaging was performed on a Leica up-right or inverted SP5 or SP8
microscope ﬁtted with a white light laser and gated Hybrid detectors. FM-4-64
stained islets were imaged using the following excitation and emission conﬁgura-
tion: YFP, Ex510nm and Em520-570nm, FM-4-64, Ex510nm and Em630–680nm.
Islet viability was checked prior to imaging with backscatter analyses20. For co-
localization studies, isolated islets or sections were mounted on 80% glycerol/PBS
(with 0.2% n-propyl gallate (NPG, Sigma) as anti-fade agent) and acquired with a
glycerol 63×/1.3NA objective with a correction collar adjusted to the focal plane
prior to imaging. Images were acquired using Nyquist acquisition parameters for
the X,Y, and Z axis and de-convolved using Huygens software (Scientiﬁc Volume
Imaging). For deconvolution, the signal-to-noise ratio was determined for each
channel and the deconvolution parameters set for 40 iterations and a quality
threshold of 0.05. Co-localization was determined with IMARIS software (Bitplane)
co-localization module and automatic thresholding for each channel. Imaging of
mouse pancreatic sections from animals fed with a CD or HFD was performed in
samples mounted in Prolong® antifade solution with DAPI (ThermoFisher) and
acquired with a glycerol 100× objective. Imaging of isolated islets treated in vitro,
was performed in PBS with a water-immersion 25 × /0.95NA objective. Somatos-
tatin was imaged with Alexa488 secondary antibodies and TPM with an excitation
line of 800 nm. For simulations determining the reach and contact density of delta
cells in mouse and human islets, we utilized a 3D tissue analysis ImageJ algorithm
as previously described29.
In vivo Ca2+ trace imaging data extraction and analysis. Extraction of in vivo
delta cell Ca2+ traces (i.e., raw GcAMP3 signal) was done in MATLAB using the
CaImAn plugin as previously described48. In brief, we used the “demo script”
within the CaImAn package to extract the Ca2+ data from movement-corrected
and background-subtracted GCaMP3 image stacks. We used the script to identify
cells (i.e., regions of interest, ROIs) automatically (CaImAn parameters: K= 50,
tau= 10, and p= 1) and normalized the GCaMP3 signal to the highest intensity
peak in each cell. As a second step, the software-detected ROIs were manually
curated to make sure that only ROIs representing cells were selected for analysis.
Next, we ran a peak-ﬁnding function and considered all peaks that met the arbi-
trary threshold of 1× higher than the standard deviation of the whole in vivo
recording for each cell. This threshold was chosen because it could detect peaks in
all control and HFD-fed animals imaged in vivo, where the latter have overall lower
peak amplitudes that could not be detected with higher thresholds. Next, the peak
location and amplitude for each cell was plotted and analyzed using excel software.
In addition, the modiﬁed demo script contains a classic MATLAB function that
integrates the normalized GCaMP3 signal from each detected cell in a given islet to
generate a hierarchical clustering analysis (HCA) (details in https://www.
mathworks.com/help/stats/hierarchical-clustering.html). Analysis of beta cell Ca2+
traces acquired via GCaMP6s imaging was done as follows: First, we calculated the
GCaMP6s/dtTomato signal intensity ratio for each identiﬁed beta cell for the entire
imaging session. Next, the ﬁles containing the GCaMP6s/dtTomato ratio were
analyzed with a custom MATLAB script that identiﬁed [Ca2+]i peaks that passed
the arbitrary threshold of 1.5× above the standard deviation for the entire imaging
experiment and for each cell. Next, the location and amplitude for all [Ca2+]i peaks
in control and SST-ChR2 islets were quantiﬁed and normalized to the highest
amplitude peak in the entire run.
Electrophysiological recordings from delta cells. Acute pancreas slices from
SSTxcre-Ai32 ChR2 eGFP mice were prepared by embedding pancreas tissue in
low-melting agarose. Tissue was sliced in ice-cold cutting solution containing (in
mM: sucrose 250, NHCO3 26, glucose 10, MgCl2 4, myo-inositol 3, KCl 2.5, sodium
pyruvate 2, NaH2PO4 2H2O 1.25, ascorbic acid 0.5, CaCl2 0.1, and kynurenic acid
1), then kept at room temperature (23 °C) in ACSF (in mM: NaCl 126, NaHCO3
24, NaH2PO4 1, KCl 2.5, CaCl2 2, MgCl2 2, glucose 4, ascorbic acid 0.4, 300–310
mOsm) bubbled with a 95% O2/5% CO2 mixture. Delta cells were identiﬁed by
their eYFP expression and their electrical signals were measured by standard
whole-cell patch-clamp recordings (10–15MΩ resistance electrodes) and K-
gluconate based internal solution (in mM: K-gluconate 130, KOH 10, MgCl2
2.5, HEPES 10, Na2ATP 4, Na3GTP 0.4, EGTA 5, Na2phosphocreatinin 5,
290–295 mOsm, 7.4 pH). Cells were current clamped at a resting potential of −70
to −75 mV and cell voltage responses to a brief light ﬂash of a mercury arc lamp
(465–495 nm, 10 ms, 1–10 Hz) were recorded via a Multiclamp 700B ampliﬁer with
Digidata 1440 A interface (Molecular Devices).
Electron microscopy of mouse and human pancreas. Small volumes of a mouse
and a human pancreas were ﬁxed and prepared for electron microscopy as
described in reference49. Islet sections were imaged with scanning and transmission
electron microscopy and delta cells identiﬁed using established guidelines for islet
electron micrographs. 3D electron tomograms of mouse delta cell ﬁlopodia were
acquired as described in reference49 and their structure was reconstructed using
IMOD software (University of Colorado).
Statistics. All statistics were performed using Graphpad Prism 7 and unless
otherwise noted, testing of signiﬁcance between experimental groups was done
using OneWay Anova with a two-stage linear step-up procedure of Benjamini,
Krieger, and Yekutieli post test to control for the false discovery rate (FDR) with a
Q value between 0.01 and 0.005.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data for Fig. 1a,c–e and g, 2d, e, and h, 3d–f, 4e, f, 5b, c and Supplementary
Figs 1a and e, 7f, 8a–c, e, f and 9a–d are provided as Source Data ﬁle. The raw data that
support the ﬁndings of this study are available from the corresponding author upon
reasonable request.
Code availability
The codes utilized to uncover/support the ﬁndings of this study are available from the
corresponding author upon reasonable request.
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